Related Experiment Video
Updated: Jan 30, 2026

Sensitive Measurement of Mitophagy by Flow Cytometry Using the pH-dependent Fluorescent Reporter mt-Keima
Published on: August 12, 2018
p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer
Hyo Won Chang1, Mi Ra Kim2, Hyang Ju Lee3
1Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Abstract:
The role of p53 in genotoxic therapy-induced metabolic shift in cancers is not yet known. In this study, we investigated the role of p53 in the glycolytic shift in head and neck squamous cell carcinoma cell lines following irradiation. Isogenic p53-null radioresistant cancer cells established through cumulative irradiation showed decreased oxygen consumption and increased glycolysis with compromised mitochondria, corresponding with their enhanced sensitivity to drugs that target glycolysis. In contrast, radioresistant cancer cells with wild-type p53 preserved their primary metabolic profile with intact mitophagic processes and maintained their mitochondrial integrity. Moreover, we identified a previously unappreciated link between p53 and mitophagy, which limited the glycolytic shift through the BNIP3-dependent clearance of abnormal mitochondria. Thus, drugs targeting glycolysis could be used as an alternative strategy for overcoming radioresistant cancers, and the p53 status could be used as a biomarker for selecting participants for clinical trials.
Insights
This study reveals that p53 protein prevents cancer cells from shifting to glycolysis after radiation. Targeting glycolysis may overcome radioresistant cancers, with p53 status guiding patient selection.
Area of Science:
- Oncology
- Cancer Metabolism
- Molecular Biology
Background:
- The role of p53 in metabolic shifts induced by genotoxic cancer therapies remains unclear.
- Understanding these shifts is crucial for developing effective cancer treatments.
Purpose of the Study:
- To investigate the function of p53 in the metabolic reprogramming of head and neck squamous cell carcinoma cells post-irradiation.
- To explore the link between p53, mitophagy, and metabolic adaptation in radioresistant cancer cells.
Main Methods:
- Established isogenic p53-null and wild-type radioresistant head and neck squamous cell carcinoma cell lines.
- Assessed cellular respiration, glycolysis, mitochondrial integrity, and mitophagy.
- Investigated the role of BNIP3 in p53-mediated mitophagy.
Main Results:
- p53-null cells exhibited decreased oxygen consumption, increased glycolysis, and mitochondrial dysfunction, enhancing sensitivity to glycolysis inhibitors.
- Wild-type p53 cells maintained metabolic profiles and mitochondrial integrity via mitophagy.
- A novel p53-mitophagy pathway (BNIP3-dependent) was identified, limiting the glycolytic shift by clearing damaged mitochondria.
Conclusions:
- p53 plays a critical role in preventing radioresistant cancer cells from adopting a glycolytic phenotype.
- Targeting glycolysis presents a potential strategy to treat radioresistant cancers.
- p53 status can serve as a biomarker for patient stratification in clinical trials for glycolysis-targeting drugs.
Related Concept Videos
Other Glycolytic Pathways
Limiting Reactant
The Number e as a Limit
Types of Limits I
Limit Laws I
Introduction to Limits

